Clinical features of unilateral acute idiopathic maculopathy identified

Article

According to a study in the Archives of Ophthalmology visual recovery of unilateral acute idiopathic maculopathy is linked with structural changes, suggesting that inflammation of the inner choroid, retinal pigment epithelium and partially reversible outer photoreceptor complex are involved in the cause of the disease.

According to a study in the Archives of Ophthalmology visual recovery of unilateral acute idiopathic maculopathy is linked with structural changes, suggesting that inflammation of the inner choroid, retinal pigment epithelium and partially reversible outer photoreceptor complex are involved in the cause of the disease.

A team led by Dr Cecilia S. Jung, Department of Vitreoretinal Surgery and Disease, Emory University, Atlanta, Georgia, USA, conducted a retrospective review on 4 unilateral acute idiopathic maculopathy patients. Clinical characteristics including age, symptoms, Snellen visual acuity and fundoscopic features were analysed. Images from spectral-domain optical coherence tomography (SD-OCT), fundus autofluorescence, fluorescein angiography and indocyanine green angiography were also evaluated.

Viral prodome, orchitis, hand-foot-mouth disease and positive coxsackievirus titers were among the associated findings present in the patients. Median visual acuity improved from 20/400 to 20/30 at follow-up, with a median follow-up time of 8 weeks.

The central macula developed irregular, circular white-grey areas of discolouration during the early stages of disease. SD-OCT presented with a partially reversible disruption of the outer photoreceptor layer.

Irregular early hyperfluorescence and late subretinal hyperfluorescence was identified with fluorescein angiography. Choroidal inflammation was found with indocyanine green angiography.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.